ProductFormStrengthIndicationTherapeutic AreaDossier Availability

Apixaban

FC Tablets

2.5mg, 5mg

Thromboembolic Disorders

Blood and Blood Forming Organs

Available

Apremilast

FC Tablets

10mg, 20mg, 30mg

Psoriasis and Psoriatic Arthritis

Antineoplastic and Immunomodulating Agents

Available

Binimetinib

NEW

FC Tablets

15mg,

45mg NEW

Melanoma

Antineoplastic and Immunomodulating Agents

Q3 2026

Bosutinib

FC Tablets

100mg, 400mg, 500mg

Leukemia

Antineoplastic and Immunomodulating Agents

Available

Budesonide

Modified-release Capsules, hard

3mg

Crohn´s disease

Alimentary Tract and Metabolism

Available

Cabozantinib

NEW

FC Tablets

20mg, 40mg, 60mg

Kidney, Liver and Thyroid Cancer

Antineoplastic and Immunomodulating Agents

Q1 2027

Eliglustat

Hard Capsules

84mg

Gaucher disease

Alimentary Tract and Metabolism

Q1 2025

Eltrombopag

FC Tablets

25mg, 50mg, 75mg

Thrombocytopenia

Blood and Blood Forming Organs

Available

Enzalutamide

FC Tablets

40mg, 80mg, 160mg

Prostate cancer

Antineoplastic and Immunomodulating Agents

Q2 2026

Eslicarbazepine

Tablets

200mg, 800mg

Epilepsy

Nervous System

Available

Fingolimod

Hard Capsules

0.25mg, 0.5mg

Relapsing multiple sclerosis

Antineoplastic and Immunomodulating Agents

Available

Ibrutinib

NEW

FC Tablets

140mg, 280mg, 420mg, 560mg

Leukemia, Lymphoma

Antineoplastic and Immunomodulating Agents

Q4 2027

Isavuconazole

Hard Capsules

100mg

Aspergillosis

Anti-infectives for Systemic Use

Q1 2026

Ivacaftor

FC Tablets

75mg, 150mg

Cystic fibrosis

Respiratory System

Q4 2025

Letermovir

FC Tablets

240mg, 480mg

Prophylaxis of Cytomegalovirus Reactivation

Anti-infectives for Systemic Use

Q2 2027

Lisdexamfetamine

Hard Capsules

20mg, 30mg, 40mg, 50mg, 60mg, 70mg

ADHD

Nervous System

Q4 2024

Macitentan

FC Tablets

10mg

Pulmonary Arterial Hypertension

Cardiovascular System

Available

Ponatinib

FC Tablets

15mg, 30mg, 45mg

Leukemia

Antineoplastic and Immunomodulating Agents

Q2 2026

Raltegravir

FC Tablets

600mg

HIV

Anti-infectives for Systemic Use

Available

Rifaximin

FC Tablets

200mg

550 mg

Travellers' diarrhoea Hepatic Encephalopathy

Alimentary Tract and Metabolism

Q1 2026

Q1 2026

Rivaroxaban

FC Tablets

2.5mg, 10mg, 15mg, 20mg

Thromboembolic Disorders

Blood and Blood Forming Organs

Available

Ruxolitinib

Tablets

5mg, 10mg, 15mg, 20mg

Myelofibrosis

Antineoplastic and Immunomodulating Agents

Available

Sapropterin

Soluble Tablets

100mg

Hyperphenyl- alaninaemia

Alimentary Tract and Metabolism

Available

Teriflunomide

FC Tablets

7mg, 14mg

Relapsing Multiple Sclerosis

Antineoplastic and Immunomodulating Agents

Available

Tolvaptan

Tablets

7.5mg, 15mg, 30mg, 45mg, 60mg, 90mg

Polycystic Kidney Disease

Cardiovascular System

Available

ProductFormStrengthIndicationTherapeutic AreaDossier Availability

Apixaban

FC Tablets

2.5mg, 5mg

Thromboembolic Disorders

Blood and Blood Forming Organs

Available

Apremilast

FC Tablets

10mg, 20mg, 30mg

Psoriasis and Psoriatic Arthritis

Antineoplastic and Immunomodulating Agents

Available

Binimetinib

NEW

FC Tablets

15mg,

45mg NEW

Melanoma

Antineoplastic and Immunomodulating Agents

Q3 2026

Bosutinib

FC Tablets

100mg, 400mg, 500mg

Leukemia

Antineoplastic and Immunomodulating Agents

Available

Budesonide

Modified-release Capsules, hard

3mg

Crohn´s disease

Alimentary Tract and Metabolism

Available

Cabozantinib

NEW

FC Tablets

20mg, 40mg, 60mg

Kidney, Liver and Thyroid Cancer

Antineoplastic and Immunomodulating Agents

Q1 2027

Eliglustat

Hard Capsules

84mg

Gaucher disease

Alimentary Tract and Metabolism

Q1 2025

Eltrombopag

FC Tablets

25mg, 50mg, 75mg

Thrombocytopenia

Blood and Blood Forming Organs

Available

Enzalutamide

FC Tablets

40mg, 80mg, 160mg

Prostate cancer

Antineoplastic and Immunomodulating Agents

Q2 2026

Eslicarbazepine

Tablets

200mg, 800mg

Epilepsy

Nervous System

Available

Fingolimod

Hard Capsules

0.25mg, 0.5mg

Relapsing multiple sclerosis

Antineoplastic and Immunomodulating Agents

Available

Ibrutinib

NEW

FC Tablets

140mg, 280mg, 420mg, 560mg

Leukemia, Lymphoma

Antineoplastic and Immunomodulating Agents

Q4 2027

Isavuconazole

Hard Capsules

100mg

Aspergillosis

Anti-infectives for Systemic Use

Q1 2026

Ivacaftor

FC Tablets

75mg, 150mg

Cystic fibrosis

Respiratory System

Q4 2025

Letermovir

FC Tablets

240mg, 480mg

Prophylaxis of Cytomegalovirus Reactivation

Anti-infectives for Systemic Use

Q2 2027

Lisdexamfetamine

Hard Capsules

20mg, 30mg, 40mg, 50mg, 60mg, 70mg

ADHD

Nervous System

Q4 2024

Macitentan

FC Tablets

10mg

Pulmonary Arterial Hypertension

Cardiovascular System

Available

Ponatinib

FC Tablets

15mg, 30mg, 45mg

Leukemia

Antineoplastic and Immunomodulating Agents

Q2 2026

Raltegravir

FC Tablets

600mg

HIV

Anti-infectives for Systemic Use

Available

Rifaximin

FC Tablets

200mg

550 mg

Travellers' diarrhoea Hepatic Encephalopathy

Alimentary Tract and Metabolism

Q1 2026

Q1 2026

Rivaroxaban

FC Tablets

2.5mg, 10mg, 15mg, 20mg

Thromboembolic Disorders

Blood and Blood Forming Organs

Available

Ruxolitinib

Tablets

5mg, 10mg, 15mg, 20mg

Myelofibrosis

Antineoplastic and Immunomodulating Agents

Available

Sapropterin

Soluble Tablets

100mg

Hyperphenyl- alaninaemia

Alimentary Tract and Metabolism

Available

Teriflunomide

FC Tablets

7mg, 14mg

Relapsing Multiple Sclerosis

Antineoplastic and Immunomodulating Agents

Available

Tolvaptan

Tablets

7.5mg, 15mg, 30mg, 45mg, 60mg, 90mg

Polycystic Kidney Disease

Cardiovascular System

Available

Coripharma´s dossier list, available for out-licencing. This list was last updated in July 2024.